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Genus Acanthamoeba is an opportunistic protozoan that is widely distributed in
the environment. Within this genus, numerous species are recognized as human
pathogens, potentially causing Acanthamoeba keratitis (AK). AK is a corneal disease,
associated predominantly with contact lens (CL) wear; its epidemiology is related to
the specific Acanthamoeba genotypes. This study reports seven CL wearer, Acantha-
moeba PCR-positive patients with AK, diagnosed between January 2015 and 2018.
Patients had the diagnosis of AK 1.36 months after first symptoms. Genotyping
allowed the identification of six isolates of the T4 and one of the T8 genotypes. At first
presentation, pseudendritiformic epithelopathy/dirty epithelium (four eyes, 57.1%),
multifocal stromal infiltrates (five eyes, 71.4%), ring infiltrate (three eyes, 42.8%), and
perineuritis (one eye, 14.3%) were observed. AK was healed without later recurrence
in two eyes (28.5%) using triple-topical therapy, in three eyes (42.8%) following
additional penetrating keratoplasty. In one patient (14.3%), AK recurred following
successful application of triple-therapy and was treated successfully with repeated
triple-topical therapy and in one patient (14.3%), no follow-up data were available
after diagnosis. We could not observe correlation of genotype and clinical course or
the necessity of corneal transplantation in our case series.
Keywords: Acanthamoeba keratitis, real-time FRET PCR, sequence analysis,
clinical course
*Corresponding author; E-mail: orosz.erika@oki.antsz.hu
Acta Microbiologica et Immunologica Hungarica 66 (3), pp. 289–300 (2019)
DOI: 10.1556/030.66.2019.008
First published online March 5, 2019
1217-8950/$20.00 © 2019 Akadémiai Kiado´, Budapest
Introduction
Acanthamoeba is a genus of free-living amebae widely distributed in various
ecological environments. The spectrum ranges from natural biotopes, such as soil,
plants, air, dust, freshwater, fishes, sea water, drinking water, swimming pools,
and contact lenses (CLs). In addition, they have been isolated from animals such as
fish and mammals and also from humans [1–3].
The first cases, which clearly established Acanthamoeba as a causative agent
of disease in humans, were published in the early 1970s [4]. The pathogenesis of
AK in humans is currently studied and different Acanthamoeba genotypes have
been reported from all over the world [5].
The traditional Acanthamoeba classification has used morphological char-
acteristics, such as morphology, size, and shape [6]. Modern classification uses a
molecular biological approach based on 18S ribosomal RNA (rRNA) gene to
classify Acanthamoeba isolates as one of the 20 known genotypes (T1–T20).
Detection of Acanthamoeba can be rapidly achieved using real-time molecular
methods. Each genotype exhibits 5% or more sequence divergences between
different genotypes [7]. For diagnostic purposes, the detection of Acanthamoeba at
the genus level is sufficient to recognize whether an individual is infected or not.
Acanthamoeba keratitis (AK) is mainly present in CL wearers, especially in case
of prolonged use of CLs, unappropriate hygienic conditions (contact of the lenses
with tap water, swimming pool, dust, etc.) or in case of corneal trauma. AK is
mainly caused by isolates with T4 genotype [8–10]; however, T2, T3, T5, T6, T8,
T9, T11, T13, and T15 genotype species have also been identified in patients with
AK, as shown in Table I [11–18].
Following an appropriate clinical and also laboratory diagnosis (confocal
microscopy, polymerase chain reaction, histology, and microbiological culture)
and having Acanthamoeba in culture, it is still not possible to arrive at a conclusion
in which topical treatment could be effectively used.
Table I. Non-T4 genotype Acanthamoeba in different countries (literature data)
Acanthamoeba genotypes Report countries
T2 Iran [12]
T3 Iran [12], England [12], Austria, USA, Spain [15, 18], and Mexico [17]
T5 Austria [16] and USA [14]
T6 Austria [16]
T8 Hungary [26]
T9 Thailand [3]
T10 Austria [16]
T11 Austria [16], USA [11], and Spain [15]
T15 Italy [13]
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Our aim was to analyze the effect of Acanthamoeba genotype, isolated from
human corneal scrapings and fluid from CL storage, on clinical course of AK.
Materials and Methods
We retrospectively collected diagnostic and clinical data of patients with AK
[polymerase chain reaction (PCR) and/or culture positive], with AK diagnosis
between January 2015 and 2018 at the Department of Ophthalmology of
Semmelweis University.
Sample collection
Acanthamoeba was isolated from corneal scrapings of seven patients [three
males (43%) and four females (57%), mean age during diagnosis 30.71 years]
between January 2015 and 2018.
Culture-confirmed detection method
The seven samples of corneal scrapings were then transferred to Page’s agar
plates overlaid with heat-killed Escherichia coli and cultured at 37 °C for 10 days.
The morphology of trophozoites and cysts was studied by light microscopy,
according to Page [19]. Plates were monitored for growth of ameba microscopi-
cally, from 72 to 96 h for the presence of Acanthamoeba spp. cysts and
trophozoites under 320× and 400× magnification.
Molecular methods
Acanthamoeba was isolated from corneal scrapings of the patients and from
fluid of CL storage case. The Acanthamoeba species were isolated by dilution
method. For this purpose, the samples of corneal scrapings were suspended in
400-μl physiological saline solution (0.85%). After preparation, the DNA extrac-
tion was treated with High Pure PCR Template Preparation Kit (Roche, Germany)
according to the manufacturer’s instructions. If further processing was delayed, the
isolates were stored at 4 °C for 24 h or at −20 °C for a longer period. The DNA
amplification was performed using genus-specific primers and genus-specific
fluorescence resonance energy transfer (FRET) hybridization probes, previously
described by Orosz et al. [20]. Each experiment included one reaction mixture
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without DNA as a negative control; positive control and each specimen was run in
duplicate for real-time PCR assay in parallel.
PCR products were purified with PCR Clean-Up M Kit (Viogene, Sunville,
CA). The sequence of each amplicon was determined by cycle sequencing with
primers for the 5′-NTR region and with primers with BigDye Terminator v3.1
Cycle Sequencing Kit (Applied Biosystems, Germany) according to the manu-
facturer’s instruction. The electrophoresis was carried out using Applied Biosys-
tems 3500 Genetic Analyzer.
The 5′-NTR and VP1 gene sequences were subject to nucleotide–nucleotide
BLAST analysis [21] using the online server at the National Center for Biotech-
nology Information (http://blast.ncbi.nlm.nih.gov/Blast).
The unknown sequences were aligned with known published sequences of
the major genotypes using the alignment program MULTALIN (http://multalin.
toulouse.inra.fr/multalin) [22]. The genotypes of samples were determined based
on this comparison.
The phylogenetic tree was constructed by the neighbor-joining method of
genetic distance calculated by the MEGA 6 (http://www.megasoftware.net) [23].
Genotype identification was carried out using a real-time FRET PCR assay
based on sequence analysis of the 18S rRNA gene, and sensitivity and specificity
were evaluated in comparison with traditional parasitological techniques.
Clinical course
Observing the clinical course, we collected data on (1) time between onset of
symptoms and diagnosis of AK, (2) clinical signs of AK, (3) coinfection with
bacteria or fungi, (4) conservative treatment, (5) surgical treatment, and (6)
outcome. For the outcome, we defined “success” if no sign of active AK was
observed at least for 6 months, without the use of topical antiamebic therapy. We
defined “failure” if AK persisted or recurred.
Results
Clinical data
Seven patients with AK had the diagnosis 1.36 months after first symptoms, at
the Department of Ophthalmology of Semmelweis University as shown in Figure 1.
At the first presentation, pseudendritiformic epithelopathy/dirty epithelium
(four eyes, 57.1%), multifocal stromal infiltrates (five eyes, 71.4%), ring infiltrate
(three eyes, 42.8%), and perineuritis (one eye, 14.3%) were observed. The clinical
data are summarized in Table II.
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AK was healed without later recurrence in two eyes (28.5%) using triple-
topical therapy (TTT; polyhexamethylene biguanide, propamidine isethionate, and
antibiotics/neomycin) in three eyes (42.8%) following additional penetrating
keratoplasty.
In Patient 3, AK recurred following successful application of TTT and was
treated successfully with repeated TTT. In Patient 7, no follow-up data were
available, following diagnosis. We could not observe similarities in genotype and
clinical course or the necessity of corneal transplantation.
Cultivation
All investigated samples revealed Acanthamoeba that were able to grow at
36 °C, the approximate temperature of the human host. Microscopical cultivation
Figure 1. Clinical images of Acanthamoeba keratitis in patients 1–7. Patient 1: multifocalstromal
infiltrates. B and C: Patient 2: perineuritis (B) (arrow) and pseudodendritiformic epitheliopathy
(“dirty epithelium”) (C). D: Patient 3: multifocal stromal infiltrates and incomplete ring infiltrate
(arrow). E and F: Patient 4: multifocal stromal infiltrates (arrows) (E) and ring infiltrate (F) (arrow).
G: Patient 5: deep stromal infiltrate (arrow) and fine slightly visible multifocal stromal infiltrates.
H: Patient 6: epithelial erosion and broad ring infiltrate (arrow). I: Patient 7: multifocal stromal
infiltrates (arrow)
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was successful in six samples. Probably due to low quantity of corneal scraping in
the seventh sample, one sample showed negative result for cultivation. Further
examination of the obtained results was carried out by FRET PCR.
Molecular methods
This study reports successful PCR amplification for seven (four females and
three males) positive cases. The samples for Acanthamoeba-positive patients,
detected by PCR method, were sequenced to identify the species (NCBI Bank:
Patient_1-KF873021_T4, Patient_2-KP337296_T4, Patient_3-KU356846_T4,
Patient_4-KU356848_T4, Patient_5-KR494236_T4, Patient_6-KJ094693_T4,
and Patient_8-MF065931_T8). Sequence analysis using a BLAST search indicat-
ed an identity of >98% with Acanthamoeba 18S rRNA gene reference sequences.
It was found that the obtained sequences of amebae isolates from the cases
belonged to the T4 and T8 genotypes Acanthamoeba spp. neighbor-joining
analysis inferred relationships between the PCR products isolated from corneal
scrapings and reference strains obtained from NCBI GenBank are shown in
Figure 2, respectively.
Discussion and Conclusions
Detection of Acanthamoeba can be rapidly achieved using real-time FRET
molecular methods. For diagnostic purposes, the detection of Acanthamoeba at the
genus level is sufficient to recognize whether an individual is infected or not
[24, 25].
Literature describes T4 genotype Acanthamoeba, as the most common in the
environment; however, in AK, prevalence of T4 genotype is even more common.
The molecular analysis conducted in this study confirmed, in our series of patients,
the T4 genotype to be the most frequent cause of AK. In addition, one isolate was
T8 genotype and was first associated with AK [26]. These results are consistent
with previous findings indicating that T4 is worldwide predominant in AK
[27, 28].
Nevertheless, a heterogeneous virulence of different Acanthamoeba strains
has been observed in our case series, for different Acanthamoeba strains. In our
opinion, different reference sequences of T4 or other Acanthamoeba genotypes
may also be important in prognosting disease progression.
For an appropriate diagnosis, ophthalmological signs of AKmust be known.
These are “dirty epithelium” (pseudodendritiformic epitheliopathy), non-healing
epithelial defects or ulcer, mono- or multifocal stromal infiltrates, perineuritis, ring
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Figure 2. Phylogenetic relations of Acanthamoeba species PCR product Patient_1, Patient_2,
Patient_3, Patient_4, Patient_5, Patient_6, Patient_7 and reference strains from NCBI GenBank
inferred by neighbor-joining analysis from pairwise comparisons (180-bp fragments)
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infiltrate, and in later stages anterior syneciae, iris atrophy, secondary glaucoma,
mature cataract, scleritis and chorioretinitis, or even blindness. To date, about 75%
of ophthalmologists miss the appropriate clinical diagnosis in AK. Faulty typical
diagnosis is herpetic keratitis in most of the cases; however, bacterial or mycotic
keratitis may also be suggested [29–33]. However, cooperation between clinicians
and experts in laboratory diagnostics is indispensable, for adquate treatment in
time of these patients.
Nowadays, there is no standardized treatment of AK, as no previous
randomized controlled studies have been performed in this rare and often
heterogeneous corneal disease. In addition, Acanthamoeba cysts are often resistant
or become resistant during treatment to all available topical therapeutic options.
The therapeutic regimen used in the recent times includes biguanides (pethylene
biguanide 0.02% and chlorhexidine 0.02%), diamidine (propamidine isethionate
0.1% and hexamidine 0.1%), and antibiotics/neomycin as TTT. Antimycotic
eye drops, propidium iodide, and miltefosine may also be effective against
Acanthamoeba strains. Besides conservative treatment, in advanced cases or in
cases without response to topical therapy, penetrating keratoplasty, amniotic
membrane transplantation, or crosslinking treatment may be performed [34].
To the best of our knowledge, this is the first study to analyze a correlation
between Acanthamoeba genotype and clinical course. However, we could not
determine a relationship between both of them in these series of patients. To date,
there is no standard treatment of AK; however, we also did not find a study
analyzing relationship between genotype and Acanthamoeba susceptibility to
different agents. In our opinion, this also needs development in the following years.
There are only case series on safety and effectivity of medical and surgical
treatment of AK and to date there are no randomized controlled clinical studies. In
Hungary, we suggest topical application of polyhexamethylene biguanide, pro-
pamidine isethionate, and antibiotics/neomycin as TTT in case of AK [35].
During the first 2 days, a “surprise attack” or “flash war” is initiated
with polyhexamethylene biguanide and propamidine isethionate every quarter to
half an hour day and night. Then, until the sixth day, polyhexamethylene
biguanide and propamidine isethionate are applied every hour and only over the
day. Following 4 weeks, eyedrop use is reduced to every 2 h. In addition,
antibiotics/neomycin 5× a day is also applied for some week.
Worldwide incidence of AK increases, presumably due to the increasing use
of CLs [36, 37]. To the best of our actual knowledge, combination therapy using
diamidine, biguanide, and antibiotics should be continued in descending dosis
until 1 year.
In Hungary, AK has been developed through Acanthamoeba genotypes T4
and T8 in the past 3 years. Analyzing seven patients, we could not determine a
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relationship between Acanthamoeba genotype and clinical course of the disease.
We suggest the development of an international database on AK causative isolates
for better understanding of the disease course and better treatment of these
patients.
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